Xu Yan Selected Research

Heart Failure

1/2022	Corrigendum to "Circulating microRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure".
1/2019	Circulating MicroRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure.
12/2018	Shenfu Formula reduces cardiomyocyte apoptosis in heart failure rats by regulating microRNAs.
7/2015	Shenfu decoction as adjuvant therapy for improving quality of life and hepatic dysfunction in patients with symptomatic chronic heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xu Yan Research Topics

Disease

56	Neoplasms (Cancer) 03/2024 - 01/2010
15	Hypoxia (Hypoxemia) 10/2023 - 01/2014
14	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 11/2008
14	Infections 10/2023 - 01/2015
13	Breast Neoplasms (Breast Cancer) 03/2024 - 10/2013
11	Inflammation (Inflammations) 04/2024 - 01/2010
10	Glioma (Gliomas) 01/2023 - 01/2018
9	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2014
9	Fibrosis (Cirrhosis) 01/2022 - 07/2011
9	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2015
8	Parkinson Disease (Parkinson's Disease) 01/2023 - 02/2015
7	Obesity 06/2024 - 04/2009
7	Hyperthermia 03/2024 - 04/2020
7	Stroke (Strokes) 01/2024 - 01/2012
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 10/2009
7	Wounds and Injuries (Trauma) 04/2020 - 01/2015
7	Maternal Obesity 07/2014 - 04/2009
6	Ischemia 10/2023 - 01/2014
5	Insulin Resistance 01/2022 - 02/2008
4	Non-alcoholic Fatty Liver Disease 12/2023 - 01/2019
4	Demyelinating Diseases (Demyelinating Disease) 12/2023 - 01/2018
4	Osteoporosis 03/2023 - 09/2020
4	Pancreatitis 01/2023 - 01/2022
4	Ischemic Stroke 04/2022 - 01/2016
4	Leukemia 03/2022 - 09/2015
4	Body Weight (Weight, Body) 01/2022 - 01/2016
4	Heart Failure 01/2022 - 07/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 03/2017
3	Hematologic Neoplasms (Hematological Malignancy) 12/2023 - 06/2017
3	Cardiac Arrhythmias (Arrythmia) 10/2023 - 01/2015
3	Spinal Cord Diseases 11/2022 - 10/2016
3	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 01/2019
3	Necrosis 01/2022 - 01/2018
3	Neuroinflammatory Diseases 01/2022 - 01/2019
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2010
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2016
3	Brain Edema (Cerebral Edema) 03/2021 - 01/2016
3	Synucleinopathies 01/2021 - 02/2015
3	Carcinoma (Carcinomatosis) 01/2020 - 01/2010
3	Tauopathies 01/2020 - 01/2016
2	Communicable Diseases (Infectious Diseases) 11/2023 - 04/2020
2	Periodontitis 10/2023 - 01/2020
2	End Stage Liver Disease 03/2023 - 01/2022
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023 - 01/2022
2	Huntington Disease (Huntington's Disease) 01/2023 - 01/2022
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 03/2020
2	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2022
2	Intervertebral Disc Displacement (Herniated Disc) 11/2022 - 01/2022
2	Disease Progression 11/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 10/2023 - 11/2008
12	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2012
11	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2015
7	Small Interfering RNA (siRNA)IBA 02/2024 - 12/2012
6	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 02/2008
5	HydrogelsIBA 03/2024 - 01/2019
5	InflammasomesIBA 01/2023 - 01/2020
5	Circular RNAIBA 01/2022 - 01/2018
5	CytokinesIBA 04/2021 - 07/2011
5	Insulin (Novolin)FDA Link 07/2014 - 02/2008
4	AntigensIBA 03/2024 - 01/2016
4	Peptides (Polypeptides)IBA 01/2024 - 03/2017
4	LipidsIBA 12/2023 - 07/2011
4	VaccinesIBA 12/2023 - 01/2015
4	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2019
4	Peptide Hydrolases (Proteases)FDA Link 08/2021 - 09/2011
4	GadoliniumIBA 03/2020 - 11/2017
4	Immunoglobulin G (IgG)IBA 01/2020 - 01/2015
3	Cystatin CIBA 01/2024 - 01/2022
3	Interleukin-6 (Interleukin 6)IBA 10/2023 - 07/2011
3	LipopolysaccharidesIBA 10/2023 - 01/2019
3	cathepsin SIBA 10/2023 - 01/2017
3	Long Noncoding RNAIBA 03/2023 - 01/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2023 - 07/2011
3	Caspase 3 (Caspase-3)IBA 01/2023 - 06/2015
3	mahuang-tangIBA 12/2022 - 04/2020
3	MicellesIBA 12/2022 - 03/2017
3	PrebioticsIBA 12/2022 - 01/2021
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2010
3	EnzymesIBA 12/2021 - 12/2018
3	NF-kappa B (NF-kB)IBA 01/2021 - 04/2009
3	SynucleinsIBA 01/2021 - 02/2015
3	Therapeutic UsesIBA 12/2020 - 06/2015
3	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 12/2016
2	Connexin 43 (Connexin43)IBA 04/2024 - 10/2023
2	Cyclin D1IBA 01/2024 - 01/2016
2	CholesterolIBA 12/2023 - 01/2022
2	human ERBB2 proteinIBA 09/2023 - 01/2022
2	CateninsIBA 03/2023 - 12/2020
2	QuercetinIBA 03/2023 - 01/2022
2	naringeninIBA 01/2023 - 01/2023
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 01/2022
2	Bile Acids and Salts (Bile Acids)IBA 12/2022 - 01/2022
2	Dynamins (Dynamin)IBA 09/2022 - 09/2021

Therapy/Procedure

25	Therapeutics 12/2023 - 12/2012
14	Drug Therapy (Chemotherapy) 03/2024 - 01/2013
7	Liver Transplantation 04/2024 - 06/2013
5	Neoadjuvant Therapy 01/2022 - 09/2017
3	Injections 07/2023 - 11/2020
3	Laminoplasty 11/2022 - 10/2016